Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2

Molecular and Cellular Endocrinology

Volumn 148, Issue 1-2, 1999, Pages 129-136

  Russell, Carolyn E ^a   Hedger, Mark P ^a   Brauman, Julie N ^a   De Kretser, David M ^a   Phillips, David J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Activin; Acute phase proteins; Follistatin; HepG2 cells; Inflammation; Proliferation

Indexed keywords

ACTIVIN A; ACUTE PHASE PROTEIN; FOLLISTATIN; HAPTOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ARTICLE; CELL PROLIFERATION; GROWTH REGULATION; HEP 2 CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ACTIVINS; ACUTE-PHASE PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLISTATIN; GLYCOPROTEINS; GROWTH SUBSTANCES; HAPTOGLOBINS; HUMANS; INFLAMMATION; INHIBINS; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; LIVER NEOPLASMS; OROSOMUCOID; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033602252     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00226-3     Document Type: Article

References (35)

1. Boe A., Canosi U., Donini S., Mastrangeli R., Ythier A., Serlupi Crescenzi O. Determination of haptoglobin expression in IL-6 treated HepG2 cells by ELISA and by RNA hybridization- evaluation of a quantitative method to measure IL-6. J. Immunol. Methods. 171:1994;157-167.
2. Brosh N., Sternberg D., Honigswachs-Sha'anani J., Lee B.-C., Shav-Tal Y., Tzehoval E., Shulman L.M., Toledo J., Hacham Y., Carmi P., Jiang W., Sasse J., Horn F., Burstein Y., Zipori D. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11: Identification as a stroma-derived activin A. J. Biol. Chem. 270:1995;29594-29600.
3. Chen,W., Woodruff, T.K., Mayo, K.W., 1998. Activin signaling and induction of apoptosis in HepG2 cells. In: Proceedings of The Eightieth Annual Meeting of the Endocrine Society (Abstract P3-295).
4. DePaolo L.V. Inhibins, activins, and follistatins: the saga continues. Proc. Soc. Exp. Biol. Med. 214:1997;328-339.
5. Dinarello C.A. Interleukin-1. Cytokine Growth Factor Rev. 8:1997;253-265.
6. 3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol. Cell. Endocrinol. 61:1989;133-138.
7. Hübner G., Brauchle M., Gregor M., Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab. Invest. 77:1997;311-318.
8. Hully J.R., Chang L., Schwall R.H., Widmer H.R., Terrell T.G., Gillett N.A. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology. 20:1994;854-862.
9. Klein R., Clarke I.J., Hedger M.P., Robertson D.M. Plasma follistatin concentrations increase following lipopolysaccharide administration in sheep. Clin. Exp. Pharmacol. Physiol. 23:1996;754-755.
10. Knowles B.B., Howe C.C., Aden D.P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209:1980;497-499.
11. Kogure K., Omata W., Kanzaki M., Zhang Y.-Q., Yasuda H., Mine T., Kojima I. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology. 108:1995;1136-1142.
12. Kogure K., Zhang Y.-Q., Kanzaki M., Omata W., Mine T., Kojima I. Intravenous administration of follistatin: delivery to the liver and effect on liver regeneration after partial hepatectomy. Hepatology. 24:1996;361-366.
13. Kojima I., Mogami H., Kawamura N., Yasuda H., Shibata H. Modulation of growth of vascular smooth muscle cells by activin A. Exp. Cell Res. 206:1993;152-156.
14. Kushner I. Regulation of the acute phase reaction by cytokines. Perspect. Biol. Med. 36:1993;611-622.
15. Mackiewicz A., Ganapathi M.K., Schultz D., Brabenec A., Kushner I. Transforming growth factor-β1 affects acute phase protein synthesis and glycosylation. Ann. N.Y. Acad. Sci. 593:1990;353-354.
16. Mackiewicz A., Speroff T., Ganapathi M.K., Kushner I. Effects of cytokine combination on acute phase protein production in two human hepatoma cell lines. J. Immunol. 146:1991;3032-3037.
17. Mashima H., Kanzaki M., Nobusawa R., Zhang Y.-Q., Suzuki M., Mine T., Kojima I. Derangements in the activin-follistatin system in hepatoma cells. Gastroenterology. 108:1995;834-840.
18. Matsuguchi T., Okamura S., Kawasaki C., Niho Y. Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of α-fetoprotein. Cancer Res. 50:1990;7457-7459.
19. Matsuzaki K., Xu J., Wang F., McKeehan W.L., Krummen L., Kan M. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenic factor. J. Biol. Chem. 268:1993;12719-12723.
20. Mine T., Kojima I., Ogata E. Stimulation of glucose production by activin-A in isolated rat hepatocytes. Endocrinology. 125:1989;586-591.
21. Mine T., Yasuda H., Fujita T., Hasegawa Y. Effects of inhibin on activin A-induced glucose metabolism in rat hepatocytes. Endocrine. 5:1996;41-46.
22. Moshage H. Cytokines and the hepatic acute phase response. J. Pathol. 181:1997;257-266.
23. O'Conner A., McFarlane J., Hayward S., Takashi Y., Groome N., de Kretser D. Serum activin A and follistatin levels in human pregnancy. Proc. Endocr. Soc. Aust. 40:1997;76.
24. Phillips D.J., Hedger M.P., McFarlane J.R., Klein R., Clarke I.J., Tilbrook A.J., Nash A.D., de Kretser D.M. Follistatin concentrations in male sheep increase following sham castration/castration or injection of interleukin-1β J. Endocrinol. 151:1996;119-124.
25. Phillips D.J., de Kretser D.M., Pfeffer A., Ng Chie W., Moore L.G. Follistatin has a biphasic response but follicle-stimulating hormone is unchanged during an inflammatory episode in growing lambs. J. Endocrinol. 156:1998;77-82.
26. Robertson D.M., Foulds L.M., Prisk M., Hedger M.P. Inhibin/activin β-subunit monomer: isolation and characterization. Endocrinology. 130:1992;1680-1687.
27. Schwall R.H., Robbins K., Jardieu P., Chang L., Lai C., Terrell T.G. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology. 18:1993;347-356.
28. Shao L.-E., Frigon N.L. Jr., Sehy D.W., Yu A.L., Lofgren J., Schwall R., Yu J. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp. Hematol. 20:1992;1235-1242.
29. Takahashi S., Uchimaru K., Harigaya K., Asano S., Yamashita T. Tumor necrosis factor and interleukin-1 induce activin A gene expression in a human bone marrow stromal cell line. Biochem. Biophys. Res. Commun. 188:1992;310-317.
30. Woodruff T.K. Regulation of cellular and system function by activin. Biochem. Pharmacol. 55:1998;953-963.
31. Xu J., Matsuzaki K., McKeehan K., Wang F., Kan M., McKeehan W.L. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc. Natl. Acad. Sci. USA. 91:1994;7957-7961.
32. Xu J., McKeehan K., Matsuzaki K., McKeehan W.L. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J. Biol. Chem. 270:1995;6308-6313.
33. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., Asano S., Kojima I. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J. Clin. Invest. 92:1993;1491-1496.
34. Yu E.W., Dolter K.E., Shao L.-E., Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin. Exp. Immunol. 112:1998;126-132.
35. Zhang Y.-Q., Kanzaki M., Mashima H., Mine T., Kojima I. Norepinephrine reverses the effects of activin A on DNA synthesis and apoptosis in cultured rat hepatocytes. Hepatology. 23:1996;288-293.